Who can get it?

The vaccine is approved for people who are 18 to 64 years of age. Its safety and effectiveness in people younger than 18 or older than 64 years of age have not yet been established.

How many doses do I need?

Health Canada has approved to give 2 doses 21 days apart, based on evidence from clinical trials. Each dose contains 3.75 micrograms of virus-like particles (VLP) of SARS-CoV-2 spike (S) protein (original strain) and 0.25 millilitres of the AS03 adjuvant.

Your province or territory decides when people receive their doses of the vaccine.

These decisions are based on public health recommendations and the latest evidence.

• Find out how provinces and territories are making COVID-19 vaccine decisions

How effective is it?

According to clinical trials a week after the second dose, Medicago Covifenz® COVID-19 vaccine is 71% effective in protecting trial participants aged 18 to 64 against COVID-19.